This Mid Cap Pharma To Consider And Approve Bonus Shares

The mid cap pharma company in a BSE filing informed that the "meeting of the Board of Directors of the Company is scheduled on 10/05/2022 ,inter alia, to consider and approve a. Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2022; b. Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2022 and c. Issue of bonus shares subject to approval by the shareholders of the Company.

Ajanta Pharma founded in the year 1973 is a Mumbai-based specialty pharmaceutical company that is into developing, producing and marketing a range of branded and generic formulations.

Importantly, the company this year also announced a buyback at a price of Rs. 2550 for which the stock turned ex-date on January 13, 2022.

Established in 1973 and headquartered in Mumbai-India, Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of finished dosages in domestic and international markets.

Last the shares of the company settled higher by 4.77% at Rs. 1803.15 per share on the NSE.